{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:56:17Z","timestamp":1793350577142,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93020C00038"],"award-info":[{"award-number":["75N93020C00038"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1K08AI168487"],"award-info":[{"award-number":["1K08AI168487"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.vaccine.2024.06.049","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T08:52:05Z","timestamp":1720601525000},"page":"126082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Need for strategic communications and stakeholder engagement to advance acceptability of an overdose preventing vaccine targeting fentanyl"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1299-0008","authenticated-orcid":false,"given":"Elissa R","family":"Weitzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney E.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Blakemore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Murdock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asimenia","family":"Angelidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.06.049_b0005","unstructured":"Ahmad F, Cisewski J, Rossen L, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. Published 2023. Accessed May 21, 2024. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates#:\u223c:text=Any%20opioid%20includes%20prescription%20opioids,2019%20to%2081%2C806%20in%202022."},{"issue":"10","key":"10.1016\/j.vaccine.2024.06.049_b0010","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/pan.13993","article-title":"Epidemiology of pediatric surgery in the united states","volume":"30","author":"Rabbitts","year":"2020","journal-title":"Pediatr Anesth"},{"issue":"2","key":"10.1016\/j.vaccine.2024.06.049_b0015","doi-asserted-by":"crossref","first-page":"20182752","DOI":"10.1542\/peds.2018-2752","article-title":"Youth and the opioid epidemic","volume":"143","author":"Levy","year":"2019","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.vaccine.2024.06.049_b0020","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.7326\/M23-0852","article-title":"Moving naloxone over the counter is necessary but not sufficient","volume":"176","author":"Messinger","year":"2023","journal-title":"Ann Intern Med"},{"issue":"52","key":"10.1016\/j.vaccine.2024.06.049_b0025","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2121094118","article-title":"Inner workings: Using vaccines to harness the immune system and fight drugs of abuse","volume":"118","author":"Shaffer","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2024.06.049_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.882491","article-title":"Current trends and perspectives in the immune therapy for substance use disorders","volume":"13","author":"Vasiliu","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.vaccine.2024.06.049_b0035","unstructured":"Development of Novel Immunotherapies for Opioid Addiction. National Institute of Health. Published 2022. Accessed August 30, 2022. https:\/\/heal.nih.gov\/research\/medication-options\/immunotherapies."},{"key":"10.1016\/j.vaccine.2024.06.049_b0040","unstructured":"CDC National Center for Health Statistics. Drug Overdose Deaths in the U.S. Top 100,000 Annually. Centers for Disease Control and Prevention. Published 2021. Accessed August 30, 2022."},{"issue":"11","key":"10.1016\/j.vaccine.2024.06.049_b0045","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.tips.2018.08.001","article-title":"Immunopharmacotherapies for Treating opioid use disorder","volume":"39","author":"Banks","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"50","key":"10.1016\/j.vaccine.2024.06.049_b0050","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.15585\/mmwr.mm7150a2","article-title":"Drug overdose deaths among persons aged 10\u201319 Years \u2014 United States, July 2019\u2013December 2021","volume":"71","author":"Tanz","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.06.049_b0055","doi-asserted-by":"crossref","unstructured":"E.R. Weitzman J. Kossowsky L.M. Blakemore et al. Acceptability of a fentanyl vaccine to Prevent opioid overdose and need for personalized decision-making Clin Infect Dis 75 Supplement_1 2022 S98 S109 10.1093\/cid\/ciac344.","DOI":"10.1093\/cid\/ciac344"},{"issue":"4","key":"10.1016\/j.vaccine.2024.06.049_b0060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/hv.5.4.7310","article-title":"Vaccines against nicotine","volume":"5","author":"Cerny","year":"2009","journal-title":"Hum Vaccin"},{"issue":"11","key":"10.1016\/j.vaccine.2024.06.049_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112368","article-title":"Anti-cocaine IgA rather than IgG mediates vaccine protection from cocaine use","volume":"14","author":"Kosten","year":"2022","journal-title":"Pharmaceutics"},{"issue":"25","key":"10.1016\/j.vaccine.2024.06.049_b0070","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1021\/jacs.7b03334","article-title":"Development of a clinically viable heroin vaccine","volume":"139","author":"Bremer","year":"2017","journal-title":"J Am Chem Soc"},{"issue":"2","key":"10.1016\/j.vaccine.2024.06.049_b0075","doi-asserted-by":"crossref","DOI":"10.1021\/acsptsci.3c00228","article-title":"Multivalent vaccination strategies protect against exposure to polydrug opioid and stimulant mixtures in mice and rats","volume":"7","author":"Song","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.vaccine.2024.06.049_b0080","doi-asserted-by":"crossref","unstructured":"Samuelsson E, Wallander L. Disentangling practitioners\u2019 perceptions of substance use severity: A factorial survey. 2014;22(4):348-360. https:\/\/doi.org\/10.3109\/16066359.2013.856887.","DOI":"10.3109\/16066359.2013.856887"},{"issue":"5","key":"10.1016\/j.vaccine.2024.06.049_b0085","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/YCO.0000000000000351","article-title":"Stigma and substance use disorders: an international phenomenon","volume":"30","author":"Yang","year":"2017","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.vaccine.2024.06.049_b0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-publhealth-090419-102240","article-title":"Vaccine hesitancy, acceptance, and anti-vaccination: Trends and future prospects for public health","volume":"42","author":"Dub\u00e9","year":"2021","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.049_b0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-019-0957-4","article-title":"Harnessing the power of theorising in implementation science","volume":"14","author":"Kislov","year":"2019","journal-title":"Implement Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2024.06.049_b0100","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s10488-013-0486-4","article-title":"Innovation adoption: a review of theories and constructs","volume":"41","author":"Wisdom","year":"2014","journal-title":"Adm Policy Ment Health"},{"key":"10.1016\/j.vaccine.2024.06.049_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/frhs.2023.1208458","article-title":"\u201cWhen you get the HPV vaccine, it will prevent cervical cancer; it will act as a shield\u201d: adolescent girls\u2019 knowledge and perceptions regarding the human papillomavirus vaccine in Zambia","volume":"3","author":"Lubeya","year":"2023","journal-title":"Frontiers in health services"},{"issue":"10","key":"10.1016\/j.vaccine.2024.06.049_b0110","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1080\/10826084.2022.2092150","article-title":"First responders\u2019 views of naloxone: Does stigma matter?","volume":"57","author":"Kruis","year":"2022","journal-title":"Subst Use Misuse"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.049_b0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13989","article-title":"The neurobiology of addiction","volume":"1451","author":"Uhl","year":"2019","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2024.06.049_b0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.15288\/jsa.1994.55.159","article-title":"Models of alcoholism used in treatment: Contrasting AA and other perspectives with which it is often confused","volume":"55","author":"Miller","year":"1994","journal-title":"J Stud Alcohol"},{"key":"10.1016\/j.vaccine.2024.06.049_b0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-clinpsy-021815-093546","article-title":"History of the concept of addiction","volume":"12","author":"Nathan","year":"2016","journal-title":"Annu Rev Clin Psychol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.049_b0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2015.11.027","article-title":"Common brain mechanisms of chronic pain and addiction","volume":"89","author":"Elman","year":"2016","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.vaccine.2024.06.049_b0135","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","article-title":"Prevention and treatment of opioid misuse and addiction: A review","volume":"76","author":"Volkow","year":"2019","journal-title":"JAMA Psychiat"},{"issue":"15","key":"10.1016\/j.vaccine.2024.06.049_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20156480","article-title":"Unpacking psychological vulnerabilities in deaths of despair","volume":"20","author":"Song","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.vaccine.2024.06.049_b0145","first-page":"434","article-title":"Current status of vaccines for substance use disorders: A brief review of human studies","author":"Truong","year":"2022","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2024.06.049_b0150","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5964\/ejop.v16i3.3107","article-title":"The theory of planned behavior: Selected recent advances and applications","volume":"16","author":"Bosnjak","year":"2020","journal-title":"Eur J Psychol"},{"key":"10.1016\/j.vaccine.2024.06.049_b0155","article-title":"Why do Hong Kong parents have low intention to vaccinate their children against COVID-19? Testing health belief model and theory of planned behavior in a large-scale survey","volume":"40(19):2772","author":"Bin","year":"2022","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2024.06.049_b0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.vaccine.2024.06.049_b0165","unstructured":"NVIVO: World Class Data Analysis Software. QSR International. Published 2022. Accessed August 30, 2022. https:\/\/www.qsrinternational.com\/nvivo-qualitative-data-analysis-software\/home."},{"issue":"11","key":"10.1016\/j.vaccine.2024.06.049_b0170","doi-asserted-by":"crossref","first-page":"e30642","DOI":"10.2196\/30642","article-title":"COVID-19 vaccine hesitancy on social media: Building a public twitter data Set of antivaccine content, vaccine misinformation, and conspiracies","volume":"7","author":"Muric","year":"2021","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.vaccine.2024.06.049_b0175","series-title":"Stuck: How vaccine rumors start\u2013 and why they don\u2019t go away","author":"Larson","year":"2020"},{"issue":"5","key":"10.1016\/j.vaccine.2024.06.049_b0180","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1097\/INF.0000000000003499","article-title":"Effective approaches to combat vaccine hesitancy","volume":"41","author":"Tuckerman","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2024.06.049_b0185","article-title":"How are advocates talking about vaccination? An analysis of field","author":"Ford","year":"2022","journal-title":"Communications"},{"key":"10.1016\/j.vaccine.2024.06.049_b0190","doi-asserted-by":"crossref","unstructured":"F.F. Schmitzberger K.W. Scott W. Nham et al. Identifying Strategies to Boost COVID-19 Vaccine Acceptance in the United States RAND Corporation 2021 https:\/\/doi.org\/10.7249\/RRA1446-1.","DOI":"10.7249\/RRA1446-1"},{"issue":"S1","key":"10.1016\/j.vaccine.2024.06.049_b0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/1475-6773.13910","article-title":"Co-creating a theory of change to advance COVID-19 testing and vaccine uptake in underserved communities","volume":"57","author":"Stadnick","year":"2022","journal-title":"Health Serv Res"},{"key":"10.1016\/j.vaccine.2024.06.049_b0200","doi-asserted-by":"crossref","unstructured":"Stein BD, Kilmer B, Taylor J, et al. America\u2019s Opioid Ecosystem: How Leveraging System Interactions Can Help Curb Addiction, Overdose, and Other Harms. America\u2019s Opioid Ecosystem: How Leveraging System Interactions Can Help Curb Addiction, Overdose, and Other Harms. Published online March 16, 2023. https:\/\/doi.org\/10.7249\/RRA604-1.","DOI":"10.7249\/RRA604-1"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.049_b0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s13181-015-0521-9","article-title":"Chronic pain, chronic opioid addiction: A complex nexus","volume":"12","author":"Salsitz","year":"2016","journal-title":"J Med Toxicol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.049_b0210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/08897077.2020.1748162","article-title":"Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study","volume":"43","author":"Smolina","year":"2022","journal-title":"Subst Abus"},{"issue":"5","key":"10.1016\/j.vaccine.2024.06.049_b0215","doi-asserted-by":"crossref","first-page":"e1169","DOI":"10.1542\/peds.2015-1364","article-title":"Prescription opioids in adolescence and future opioid misuse","volume":"136","author":"Miech","year":"2015","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2024.06.049_b0220","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s40429-023-00489-0","article-title":"\u201cCulturally Responsive\u201d substance use treatment: Contemporary definitions and approaches for minoritized racial\/ethnic groups","volume":"10","author":"Banks","year":"2023","journal-title":"Curr Addict Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2024.06.049_b0225","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3109\/10826084.2010.548435","article-title":"Harm reduction and 12 steps: complementary, oppositional, or something in-between?","volume":"46","author":"Lee","year":"2011","journal-title":"Subst Use Misuse"},{"issue":"1","key":"10.1016\/j.vaccine.2024.06.049_b0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1300\/J160v01n01_09","article-title":"Harm reduction and abstinence based recovery: A dialogue","volume":"1","author":"Acsw","year":"2001","journal-title":"J Soc Work Pract Addict"},{"key":"10.1016\/j.vaccine.2024.06.049_b0235","unstructured":"The A.A. Member\u2014Medications and Other Drugs | Alcoholics Anonymous. Accessed September 13, 2023. https:\/\/www.aa.org\/aa-member-medications-and-other-drugs."},{"issue":"2","key":"10.1016\/j.vaccine.2024.06.049_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008064","article-title":"Stop: Study, treat, observe, and prevent neglected diseases of poverty act","volume":"14","author":"Hotez","year":"2020","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:20:24Z","timestamp":1777537224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24007229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":48,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0264410X24007229"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Need for strategic communications and stakeholder engagement to advance acceptability of an overdose preventing vaccine targeting fentanyl","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126082"}}